BILLEV PHARMA ApS: Financial statements 2017
CVR: 81814813
Source: annual report 2017, Danish Business Authority
01/05/2016 – 30/04/2017
BILLEV PHARMA ApS (CVR 81814813) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 14,556,638 and a net result of DKK 2,120,209 compared with DKK 2,007,612 the year before. Equity in the 2017 report amounted to DKK 2,440,209. The solvency ratio was 50.7%. The company had 13 employees in the financial year.
- Gross Profit
- DKK 14,556,638
- Profit/Loss
- DKK 2,120,209
- Equity
- DKK 2,440,209
- Total Assets
- DKK 4,816,115
- Employees
- 13
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 14.6 mio. | 2.1 mio. | 2.4 mio. | 13 |
| 2016 | - | - | 2 mio. | 2.3 mio. | - |
| 2015 | - | 9.7 mio. | 636 t. | 956 t. | - |
| 2014 | - | 9.7 mio. | 517 t. | 1.5 mio. | - |
| 2013 | - | 9.4 mio. | 728 t. | 2.4 mio. | - |
Keep an eye on BILLEV PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout BILLEV PHARMA ApS
BILLEV PHARMA ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 1977. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Ulrikke Lynge Jensen and Anja Wencke van Arkens. The company is owned by VAN ARKENS HOLDING ApS and UL JENSEN HOLDING ApS. The company has 15 employees (2018). In 2026, the company reported a gross profit of DKK 38,801,270 and a net result of DKK 10,205,639 compared with DKK 6,143,854 the year before. Equity in the 2026 report amounted to DKK 10,525,639.